Recoverable Translational Research Grants
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Faculty and non-faculty investigators
Other requirements
- Researchers with early-stage cancer projects
- Future competitions anticipated for Salisbury Award winners and other qualified candidates
- Geographic Scope: International
Overview
Purpose: Multiyear grants designed to catalyze promising laboratory cancer research and support the translational research phase—the segue between basic and applied research where laboratory findings are validated and viable candidates are put on the path toward human clinical trials and patient use.
Award Structure:
- Multiyear grants
- Recoverable grant model (repayment expected upon commercialization success)
- Nine grants awarded over two years (as of 2019)
Translational Research Focus:
- Often vastly under-resourced research phase
- Supports the continuum where cancer findings are validated
- Bridges gap to human clinical trials and patient use
- Focuses on viable therapeutic, diagnostic, and preventive candidates
Eligibility:
- Researchers with early-stage cancer projects
- Future competitions anticipated for Salisbury Award winners and other qualified candidates
- Faculty and non-faculty investigators
Geographic Scope: International
Contact:
- Bradley Gillenwater, Senior Director Global Program Development
- Email: bgillenwater@nfcr.org
- Phone: 301-961-9161
- Address: 5515 Security Lane, Suite 1105, Rockville, MD 20852
- General: 1-800-321-CURE (2873) or info@nfcr.org
What National Foundation For Cancer Research actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 20
- Total given
- $3.33M
- Median grant
- $140K
- Range
- $5,912–$870K
- By dollars: Maryland 29%, New York 17%, Massachusetts 15%. Top recipient cities: New York, NY; Boston, MA; La Jolla, CA.
- 0% of grants with a stated purpose were for general or operating support.
- 20% of recipients were new grantees, not repeat recipients.
Example grants
Aim Hi Accelerator Fund · Rockville, MD
collaboration
$870K
Massachusetts General Hospital · Boston, MA
Research contracts
$352K
Columbia University · New York, NY
Research contracts
$250K
Yale University · New Haven, CT
Research contracts
$230K
University of Pennsylvania · Philadelphia, PA
Research contracts
$211K
Focus Areas & Funding Uses
Fields of Work
- Cancer
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Salisbury Award for Entrepreneurial Translational Research
National Foundation For Cancer Research
Amount
$3,000 (winner), $1,500 (runner-up)
Deadline
Deadline not published
AIM-HI Accelerator Fund (Aim-Hi Accelerator Fund)
National Foundation For Cancer Research
Amount
Varies
Deadline
Deadline not published
AAPM Early Investigator Research Grant
American Academy of Pain Medicine
Amount
Varies
Deadline
Deadline not published
BRACE Award Venture Competition
Aim-Hi Accelerator Fund Inc
Amount
Up to US$600,000 in investment funding
Deadline
Deadline not published
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $300,000
Deadline
November 10, 2026
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $150,000
Deadline
November 10, 2026
Ready to apply for Recoverable Translational Research Grants?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Recoverable Translational Research Grants. Now let's win it.